Debate on ethics of tobacco funding

Jul 19, 2007

University of California officials said they will discuss in September whether it will accept additional research funding from the tobacco industry.

Members of the University of California Board of Regents said in Santa Barbara Wednesday they want to balance the university's integrity, while protecting academic freedom, The Los Angeles Times reported Thursday.

The board is torn between members who oppose accepting any more tobacco money and those who contend the university should trust the faculty to decide what grants to accept.

"Passions run high on every side of this issue," board Chairman Richard Blum, who supports a ban, said in the newspaper article.

Researchers at seven of University of California 's 10 campuses are conducting research under 23 grants from Philip Morris USA, totaling $16,647,661, the University of California Office of Research told the Times.

U.S. District Judge Gladys Kessler ruled in a federal racketeering case last year that the major U.S. tobacco companies conspired for decades to deceive the public and had manipulated research to make it appear that scientists disagreed on the effects of second-hand smoke.

Copyright 2007 by United Press International

Explore further: Can science eliminate extreme poverty?

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Can science eliminate extreme poverty?

18 hours ago

Science has often come to the rescue when it comes to the world's big problems, be it the Green Revolution that helped avoid mass starvation or the small pox vaccine that eradicated the disease. There is ...

Japan stem cell body splashes cash on luxury furniture

Apr 14, 2014

A publicly-funded research institute in Japan, already embattled after accusing one of its own stem cell scientists of faking data, has spent tens of thousands of dollars on designer Italian furniture, reportedly to use up ...

User comments : 0

More news stories

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

'Chief Yahoo' David Filo returns to board

Yahoo announced the nomination of three new board members, including company co-founder David Filo, who earned the nickname and formal job title of "Chief Yahoo."